Comparison of Medical Device Regulations in India, Japan and South Korea

被引:0
|
作者
Chandan, B., V [1 ]
Venkatesh, M. P. [1 ]
Arjun, M. [1 ]
Krishna, Pasupuleti Dheeraj [1 ]
Indraprasad, S. [1 ]
机构
[1] JSS Coll Pharm, JSS Acad Higher Educ & Res, Dept Pharmaceut, Mysuru 570015, Karnataka, India
关键词
Medical device; regulatory process; registration; amendments; functionalities; classifications; CDSCO (the central drug standard control organisation); KFDA (korea food and drug administration); MFDS (ministry of food and drug safety);
D O I
10.9734/JPRI/2021/v33i53A33634
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increased health awareness, a growing middle class, and government health efforts are projected to propel India's medical equipment market forward in the next years. With the publication of the Medical Device Rules in 2017, Indian authorities revised the medical device regulatory process. The devices included in the link are currently regulated medical devices and in vitro diagnostic devices, as well as their classifications. CLA (Central Licensing Authority) is in charge of all import device licencing, as well as manufacturing, loan, and wholesale licences for Class C and Class D medical devices. Because of its complicated registration process and linguistic obstacles, Japan is regarded one of the most difficult markets for overseas medical device producers. The Pharmaceutical and Medical Device Agency, which works in tandem with the MHLW (Ministry of Health and Labour Welfare), is in charge of reviewing drug and medical device applications in Japan. The Pharmaceuticals and Medical Devices Act is a federal law that regulates the sale of pharmaceuticals and medical devices. The Pharmaceuticals and Medical Devices Act, also known as the Act on Securing Quality, Efficacy, and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics, lays out the current PMDA (Pharmaceuticals and Medical devices Agency) laws in Japan. South Korea is one of the largest health-care markets in the Asia-Pacific region. Medical Devices in South Korea are regulated by the Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food and Drug Administration (KFDA). Medical Devices in South Korea are regulated by the Ministry of Food and Drug Safety, formerly known as the Korea Food and Drug Administration. The Medical Device Act of 2015 governs current medical device laws in Korea. To access the South Korean Medical-Device-Market, you must first obtain marketing approval from the local Medical Device Authority, the Medical Device Information & Technology Centre, which is part of the Ministry of Food and Drug Safety. With the MFDS notification No. 2020-29, the South Korean Ministry of Food and Drug Safety launched UDI (Unique Device Identification System) operations in 2018. Article 20 of the Medical Device Act and Article 54-2 of the Medical Device Act Enforcement Regulations make UDI compliance mandatory.
引用
收藏
页码:8 / 23
页数:16
相关论文
共 50 条
  • [1] Review of the Oscillation of Research Regulations for Bioethics in the Republic of Korea: Comparison with Japan
    Hyeon, Seung-Hyo
    An, Juyoung
    Ryoo, Hwa-Shin
    Lee, Min-Kyu
    [J]. BIOTECH, 2023, 12 (02):
  • [2] Updates on the regulations in South Korea
    Zhou, Bryan
    [J]. Farbe und Lack, 2023, 129 (01): : 66 - 67
  • [3] Psychoanalysis in Asia: China, India, Japan, South Korea and Taiwan
    Narayanan, Amrita
    [J]. PSYCHODYNAMIC PRACTICE, 2015, 21 (02) : 200 - 203
  • [4] Business groups in Japan, South Korea, and Taiwan: A comparison
    Liu, JC
    Choi, JP
    Wang, HH
    [J]. RESEARCH IN ASIAN ECONOMIC STUDIES, VOL 8 - 1998, 1998, 8 : 351 - 360
  • [5] The Comparison of Animation Industries of US, Japan, South Korea and China
    Ren Guoqiang
    Jin Weijie
    [J]. PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON LOGISTICS SYSTEMS AND INTELLIGENT MANAGEMENT, VOLS 1-3, 2010, : 1901 - 1904
  • [6] Ecosystem of the medical device industry in South Korea: A Network Analysis Approach
    Lee, Munjae
    Yoon, Kichan
    [J]. HEALTH POLICY AND TECHNOLOGY, 2018, 7 (04) : 397 - 408
  • [7] Analysis of the high-risk age group of suicide in South Korea-Comparison of Japan and South Korea
    Inoue, Ken
    Tanii, Hisashi
    Nata, Masayuki
    Fujita, Yoshitsugu
    Ono, Yuichiro
    [J]. JOURNAL OF FORENSIC AND LEGAL MEDICINE, 2009, 16 (02) : 104 - 105
  • [8] The Experiences of Japan and South Korea on
    Wang Yanjun
    Zhang Jiarui
    [J]. China Population Today, 2016, 33 (01) : 49 - 49
  • [9] Cancer burden and trends in China: A review and comparison with Japan and South Korea
    Dianqin Sun
    Maomao Cao
    He Li
    Siyi He
    Wanqing Chen
    [J]. Chinese Journal of Cancer Research, 2020, 32 (02) : 129 - 141